A study presented at the 2025 Annual Meeting of the American Academy of Orthopaedic Surgeons examined the relationship between the patient's last dose of Ozempic, a common GLP-1, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback